NAVMEDCOMINST 6230.2 Flashcards Preview

ADVANCEMENT BIB > NAVMEDCOMINST 6230.2 > Flashcards

Flashcards in NAVMEDCOMINST 6230.2 Deck (13):
1

Individuals treated for malaria must wait ____ years from the date treatment was finished until they are eligible to donate blood.


3 years

2


Individuals who were in malaria-risk areas and were required to take chemoprophylaxis because of a perceived risk of exposure must wait ____ years fro the time chemoprophylaxis was finished.


3 years

3

Individuals who visited malaria-risk area and remained asymptomatic, but were not required to take chemoprophylaxis because of negligible risk of exposure must wait how many months to donate blood?


6 months

4

True or False. All Navy, Marine Corps, and MSC personnel must have a documented g6pd test result on their health record


True

5

Any person who is G-6-PD deficient has a risk of hemolysis associated with taking ______ for chemoprophylaxis.


Primaquine

6


Report suspected or confirmed malaria cases in a _____ .

Disease Alert Report. A malaria DAR should include the patient's itinerary during the previous 3 months and the types and duration of any chemoprophylaxis or treatment medication taken

7


What are the vectors of malaria?


Anopheline mosquito

8


What are the chemoprophylaxis for malaria?

Traditionally, chloroquine and primaquine has been effective. Due to resistance to chloroquine, regimen may require the use of pyrimethamine-sulfadoxine or doxycycline.

9


Since patterns of resistance and drug requirements change frequently, Medical Department of fleet units must contact ______-


NAVENPVNTMEDU prior to deployment to malaria-risk areas

10


What is the Wilson-Edeson Test

Screening test for the presence of chloroquine in the urine. It tests for overall compliance with taking choroquine. 15% false negative rate.

11

The most important aspect of malaria treatment is suspecting this disease in the ________ diagnosis of the patient and beginning immediate treatment.


Differential

12

The types of parenteral antimalarial drugs used to treat severe cases of malaria are:

Parenteral chloroquine hydrochloride, quidine gluconate, and quinine dihydrochloride

13

NAVMEDCOMINST 6230.2 is Malaria prevention and Control

End

Decks in ADVANCEMENT BIB Class (64):